The treatment of tuberculosis and application of HAART (highly active anti retroviral treatment) in HIV positive patients

F. Scano (Geneva, Switzerland)

Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem
Disease area: Respiratory infections

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Scano (Geneva, Switzerland). The treatment of tuberculosis and application of HAART (highly active anti retroviral treatment) in HIV positive patients. Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy
Source: Eur Respir J 2004; 24: 11-17
Year: 2004



Should tuberculosis treatment and control be addressed differently in HIV-infected and -uninfected individuals?
Source: Eur Respir J 2005; 25: 751-757
Year: 2005



The role of adherence in tuberculosis HIV-positive patients treated in ambulatory regimen
Source: Eur Respir J 2003; 21: 785-788
Year: 2003



Tuberculosis (TB) detection with HIV infected patients
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009

High completion rates with directly observed preventive treatment (DOPT) of latent tuberculosis infection (LTBI) in Ethiopian immigrants (EI) to Israel
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012

Prevalence of HIV infection among tuberculosis cases and pattern of tuberculosis and treatment outcome in HIV seropositives – a study from a tuberculosis center from India
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009

Impact of extensive drug resistance on treatment outcomes in non-HIV infected adults with MDR-TB
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007


Prevalence and treatment outcome of drug resistant pulmonary tuberculosis in HIV negative cases – experience from a tuberculosis treatment center in India
Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis
Year: 2009


A comparison of on-site versus remote physician follow up of directly observed preventive treatment (DOPT) for latent tuberculosis infection (LTBI) on completion rates
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012

Experience in the use of Bedakville in the therapy of multidrug-resistant tuberculosis and HIV infection.
Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Year: 2018

The tuberculosis in patients with HIV and AIDS
Source: Eur Respir J 2007; 30: Suppl. 51, 656s
Year: 2007

Bronchoscopy yield in HIV positive patients, ten years on from the introduction of highly active anti-retroviral therapy
Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Year: 2009


HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015

Impact of HIV status, CD4 count and antiretroviral treatment on tuberculosis treatment outcomes in a low-burden country
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017


Contribution of the T-SPOT.TB assay for differentiating active versus latent tuberculosis infection (LTBI)
Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection
Year: 2006


Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection
Source: Eur Respir J 2010; 36: 1242-1247
Year: 2010



One year follow-up of T-SPOT. TB results in treated patients with active tuberculosis
Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Year: 2007



MDR-TB treatment outcomes in HIV positive patients
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014

TB in children
Source: Eur Respir Mon 2012; 58: 206-218
Year: 2012


Characterization of the HBHA response in TB patients with or without HIV infection.
Source: International Congress 2017 – Human susceptibility to tuberculosis
Year: 2017